WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies

Mar 8, 2022

TESSA™ technology provides a scalable process for manufacturing gene therapies, accelerating the production of large quantities of therapeutic DNA required to treat patients in need New data published in Nature Communications supports the benefits of this technology...

WuXi Advanced Therapies Testing Facility To Receive EMA GMP Certificate for New Philadelphia Facility

Jan 7, 2022

January 07, 2022 – Philadelphia. WuXi Advanced Therapies (WuXi ATU) announced it has successfully completed a remote European Medicines Agency (EMA) inspection for its advanced therapies testing facility at 400 Rouse Boulevard in its Philadelphia Navy Yard Campus, and...

Partnership with WuXi Advanced Therapies to manufacture lentiviral vectors for phase I trial of cutting edge HEMO-CAR-T program

Dec 20, 2021

Hemogenyx Pharmaceuticals will leverage WuXi Advanced Therapies’ (“WuXi ATU”) plasmid and lentiviral vector manufacturing platforms, including integrated testing, to accelerate HEMO-CAR-T program for acute myeloid leukaemia (“AML”) toward phase I clinical trials....

WuXi ATU Opens New Facility in Philadelphia, Tripling Testing Capacity to Support Global Customers

Nov 15, 2021

New state-of-the-art advanced therapies testing laboratories provide additional capacity for the growing cell and gene therapy industry. November 15, 2021 – Philadelphia. WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the...

WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers

Oct 18, 2021

Philadelphia, 18 October 2021 – WuXi Advanced Therapies Inc. (WuXi ATU) – a wholly owned subsidiary of WuXi AppTec – today announced the opening of its new process development and commercial manufacturing facility in Lin-gang, Shanghai. WuXi ATU is a leading...

WuXi Advanced Therapies Appoints Ms. Michie Ong as Senior Director of Global Quality and Compliance

Apr 12, 2021

March 29, 2021 – Philadelphia, PA – We are pleased to announce that Ms. Michie Ong will be joining WuXi Advanced Therapies Unit (WuXi ATU), as Senior Director of Global Quality and Compliance. In this role, Ms. Michie Ong will be responsible for setting the...